"O Hospital das Clínicas da UFMG, administrado pela Empresa Brasileira de Serviços Hospitalares (EBSERH), é um hospital universitário, público e geral que realiza atividades de ensino, pesquisa e assistência em saúde. Integrado ao SUS, é referência estadual no atendimento a patologias de média e alta complexidade."

During the past decade, Hospital das Clínicas - Universidade Federal de Minas Gerais conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 19 clinical trials were completed, i.e. on average, 29.2% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 16 clinical trials were completed. i.e. 59.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital das Clínicas - Universidade Federal de Minas Gerais" #1 sponsor was "Federal University of Minas Gerais" with 25 trials, followed by "Janssen Research & Development, LLC" with 10 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Actelion" with 5 trials sponsored and "Janssen Vaccines & Prevention B.V." with 5 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital das Clínicas - Universidade Federal de Minas Gerais" #1 collaborator was "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 5 trials as a collaborator, "Fundação de Amparo à Pesquisa do estado de Minas Gerais" with 5 trials as a collaborator, "Ministry of Health, Brazil" with 3 trials as a collaborator, "Actoverco" with 1 trials as a collaborator and "Atea Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Hospital das Clínicas - Universidade Federal de Minas Gerais" are "Pulmonary Arterial Hypertension" (5 trials), "Depressive Disorder, Major" (3 trials), "COVID-19" (2 trials), "COVID-19 Prevention" (2 trials) and "Cancer" (2 trials). Many other conditions were trialed in "Hospital das Clínicas - Universidade Federal de Minas Gerais" in a lesser frequency.

Most popular intervention types in "Hospital das Clínicas - Universidade Federal de Minas Gerais" are "Drug" (47 trials), "Other" (18 trials), "Biological" (13 trials), "Dietary Supplement" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Ad26.COV2.S" (4 trials), "Guselkumab Dose 1" (3 trials), "Guselkumab Dose 2" (3 trials) and "Aticaprant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital das Clínicas - Universidade Federal de Minas Gerais" are 68 trials for "All" genders and 15 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital das Clínicas - Universidade Federal de Minas Gerais". undefined are not yet recruiting, 12 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Hospital das Clínicas - Universidade Federal de Minas Gerais, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital das Clínicas - Universidade Federal de Minas Gerais, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 21 trials that are defined as “Not Applicable".